Halozyme Therapeutics reported $56.53M in EBIT for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Agios Pharmaceuticals AGIO:US $ -104827000 13.68M
Aptinyx Inc APTX:US $ -19379000 207K
Cytokinetics CYTK:US $ -77857000 58.95M
Immunogen IMGN:US $ -22852000 11.7M
Intrexon XON:US $ -25469000 10.34M
IONIS PHARMACEUT IONS:US $ 221M 306.85M
Minerva Neurosciences NERV:US $ -7989260 13.39M
Nektar Therapeutics NKTR:US $ -112910000 686K
Peregrine Pharmaceuticals PPHM:US $ 4.15M 2.78M